Home Blog Page 149

NeoClinic: North India's Premier Paediatric Hospital Delivers Comprehensive, Expert-Led Care for Children Across Rajasthan and Beyond

NeoClinic Children Hospital continues to set the standard for paediatric and neonatal care in North India, offering families access to comprehensive, specialized healthcare services that combine advanced medical technology with compassionate, child-centered treatment. Since its establishment in 2010, NeoClinic has earned the trust of thousands of families across Rajasthan and neighbouring states, establishing itself as the region’s largest and most comprehensive paediatric healthcare institution.

 

https://www.newsvoir.com/images/article/image1/34636_Dr._JK_Mittal.jpeg

Redefining paediatric and newborn care through expertise, compassion, and outcomes that families trust at NeoClinic


Where Little Patients Get Big Care” isn’t just our tagline, it’s our promise to every family that walks through our doors,” says the leadership team at NeoClinic. “We’ve built North India’s most comprehensive paediatric facility because we believe every child deserves access to expert, specialized care closes to home, without families having to travel to metros like Delhi or Mumbai.”


A Complete Paediatric Healthcare Ecosystem
What distinguishes NeoClinic from other healthcare facilities is its comprehensive approach to paediatric medicine. The hospital houses an unprecedented range of paediatric super-specialties under one roof, including:

  • Advanced Cardiac Care: State-of-the-art Paediatric Cardiology services for comprehensive heart health diagnosis and treatment

  • Critical Care Excellence: Dedicated Neonatal Intensive Care Unit (NICU) and Paediatric Intensive Care Unit (PICU) equipped with world-class technology for the most vulnerable patients

  • Specialized Medical Services: Expert departments in Gastroenterology & Hepatology, Neurology, Pulmonology, Endocrinology, Rheumatology, and Orthopedics

  • Surgical Expertise: Comprehensive Paediatric Surgery services for both congenital and acquired conditions

  • Developmental Support: The Saarthak Child Development Center provides early intervention and therapy for children with developmental delays and disabilities

  • Complete Diagnostic Services: In-house Paediatric Radiology and Pathology for accurate, timely diagnoses

 

A Track Record That Speaks Volumes
Numbers tell the story of NeoClinic’s impact on children’s health across North India. In 2025 alone, the hospital served 38,281 outpatient visits and provided comprehensive inpatient care for 4,714 children, reflecting the trust families place in NeoClinic for both routine care and critical interventions.


The hospital’s surgical expertise is demonstrated through 1,554 major and minor surgeries performed in 2025, along with 543 specialized endoscopy and bronchoscopy procedures. Each procedure represents a child whose health was restored, a parent’s worry eased, and a family’s future brightened.


Over 15 years of dedicated service, NeoClinic has touched hundreds of thousands of lives, establishing itself as the paediatric healthcare destination that families across Rajasthan and neighbouring states turn to when their children need expert care. The hospital maintains a 4.7 out of 5 rating based on over 2,120 verified patient reviews, with a team of 300+ dedicated healthcare professionals including 25+ specialist doctors working across 100+ specialized paediatric beds.


Expert-Led, Evidence-Based Care
NeoClinic’s medical team represents some of the region’s most respected paediatric specialists, including renowned experts in neonatology, cardiology, gastroenterology, neurology, and paediatric surgery. The hospital’s physicians are known for their ability to handle complex cases, combining deep clinical expertise with a compassionate approach that puts families at ease during challenging times.


We don’t just treat medical conditions—we partner with families,” explains the NeoClinic team. “From the moment a family arrives, whether it’s for a routine check-up or a critical emergency, they become part of the NeoClinic family. Our evidence-based care is delivered with empathy, clear communication, and unwavering support.”


Accessible Excellence for Interstate Families
Recognizing that many families travel from across state lines to access specialized paediatric care, NeoClinic has developed comprehensive interstate patient services. The hospital works with multiple insurance partners and provides dedicated support to help families navigate logistics, accommodations, and financial aspects of care, removing barriers that might prevent children from receiving the treatment they need.


Commitment to Family Education and Prevention
Beyond acute care, NeoClinic is deeply committed to preventive medicine and family education. The hospital regularly publishes health articles, doctor’s insights, and educational resources on its website, covering everything from everyday health issues to complex medical conditions. This commitment to transparency and education empowers parents to make informed decisions about their children’s health and recognize early warning signs that require medical attention.


Looking Ahead
As NeoClinic continues to grow and expand its services, the hospital remains focused on its founding mission: to provide world-class paediatric care with the warmth, attention, and personalized service that every child and family deserves. The hospital’s leadership is committed to staying at the forefront of paediatric medicine through continuous investment in technology, training, and infrastructure.


About NeoClinic Children Hospital
Established in 2010 by Dr J.K Mittal, NeoClinic is recognized as North India’s premier paediatric hospital, serving families across Rajasthan and neighbouring states. With 100+ specialized beds, 25+ expert specialists, and a comprehensive range of paediatric super-specialties, NeoClinic provides evidence-based, compassionate care for children from birth through adolescence. The hospital’s commitment to excellence is reflected in its 4.7/5 patient rating and recognition as the region’s most trusted paediatric healthcare institution.


For more information about NeoClinic’s services, to schedule an appointment, or to learn more about specialized paediatric care, visit www.neoclinic.co or call +91 73400 61556.

Fortis Hospital, Mulund Unveils 'New-Age ER' – Setting New Benchmarks in Emergency Care

Fortis Hospital, Mulund today announced the launch of reimagined and enhanced next-generation Emergency Medicine Department (ER) – the New Age ER – designed to deliver rapid, protocol-driven, and outcome-focused emergency care. With advanced resuscitation infrastructure, and globally benchmarked workflows, the ‘New Age ER’ marks significant advancement in emergency preparedness for Mumbai. The inauguration ceremony was graced by Hon. Hemarajsingh Rajput (IPS) – Dy. Commissioner of Police (Zone 7); he was joined by Dr S. Narayani, Business Head-Fortis Hospitals Maharashtra, Dr Vishal Beri, Facility Director, Fortis Hospital Mulund & Dr Sandeep Gore, Director – Emergency Medicine, Fortis Hospital Mulund.

 

(L–R) Dr Gore; Hon. Hemarajsingh Rajput, Dy. Comm. of Police (Zone 7) Mumbai, Dr Beri & Dr S. Narayani at inauguration of the New Age ER Dept. at Fortis Hospital Mulund, Mumbai

 

This reimagined emergency set-up, now with 27 beds – including two isolation beds – integrates structured clinical pathways, advanced bedside diagnostics, and multidisciplinary coordination to manage time-sensitive emergencies such as Heart Attack, Paralysis (acute Stroke), Septicemic Shock, Polytrauma, Pulmonary Embolism, and other such acute medical emergencies, where outcomes are critically dependent on rapid response, accurate diagnosis and timely intervention. Helmed by Dr Sandeep Gore, Director-Emergency Medicine, the Emergency Medicine team at Fortis Hospital Mulund, has treated over 2lac medical emergencies over the past 15yrs, and has delivered outcomes that exceed global benchmarks

 

The department is also a pioneer in POCUS-led resuscitation and advanced Point-of-Care-Testing (POCT), enabling bedside diagnostics within minutes. Backed by 15yrs of robust clinical data and a strong culture of continuous quality improvement, the model emphasizes measurable outcomes and 24×7 specialized Emergency Medicine coverage. The ‘New Age ER’ features:

  • Dedicated high-acuity resuscitation bays with advanced monitoring & resuscitation capabilities

  • Integrated POCUS and imaging support at bedside

  • Streamlined triage and rapid treatment zones

  • Expanded observation and critical care holding areas

  • ECMO ready resuscitation capabilities

  • Fast track emergency out-patient care

  • Simulation and training space for doctors and nurses

  • Digital dashboards for real-time quality and safety monitoring

 

Dr. Sandeep Gore, Director – Emergency Medicine, Fortis Hospital, Mulund, Mumbai, who helms the ‘New Age ER’ said, “Emergency medicine today is defined by protocols, preparedness, and precision. The reimagined Emergency Department further strengthens our ability to deliver time-critical interventions through rapid triage, integrated care pathways, and round-the-clock availability of trained emergency response teams. Our data in STEMI, Stroke, Sepsis, trauma, and cardiac arrest demonstrates what structured systems can achieve in improving survival and outcomes, consistently better than global benchmarks.”

 

Representing hundreds of patients who received life-saving CPR in the hospital’s Emergency Dept., two patients joined in the inauguration today. Ms. Santoshi Kumavat (52) survived a massive Pulmonary Embolism after 35 minutes of continuous CPR. She was given Thrombolysis during ongoing resuscitation and recovered without any neurological deficit. And Ms. Vinita Bipin (50) regained pulse after 60 minutes of CPR. She then underwent primary angioplasty and made a full recovery, with no neurological damage. Such outcomes after prolonged resuscitation are considered extremely rare worldwide.

 

Hon. Hemarajsingh Rajput (IPS) – Dy. Commissioner of Police (Zone 7), said, “In an emergency, the first responder is often the traffic police officer on the road, helping isolate, stabilize and clear the way for an ambulance. Those few minutes they save can mean everything. It’s important that their efforts are backed by emergency set-ups that are fully equipped and ready to act the moment a patient is brought in. When the road and the hospital work in sync, lives are saved.”

 

Fortis Hospital, Mulund continues its efforts to strengthen emergency response networks in surrounding areas in collaboration with key civic stakeholders, traffic authorities, first responders and other local bodies. Between 2019-2026, the team at Fortis Hospital Mulund has trained 14,530 Police & Traffic personnel to administer CPR during medical emergencies. In continuation of the effort, the team will train and certify all Traffic & Police personnel across Thane-Mulund-Bhandup for emergency preparedness, including first aid administration, patient stabilization and transfer.

 

Dr. Vishal Beri, Facility Director, Fortis Hospital, Mulund, Mumbai added, “With the ‘New Age ER’, we’ve brought together advanced infrastructure and strong clinical expertise to ensure we are truly prepared when our community needs us the most. From rapid bedside diagnostics to coordinated response teams for critical emergencies, every aspect of this department has been thoughtfully designed to act quickly and efficiently. Our aim is straightforward — to give patients and families the confidence that, in an emergency, they will receive timely, dependable, and high-quality care they can trust.”

 

Designed for speed, science, and survival, the ‘New Age ER’ at Fortis Hospital, Mulund sets a benchmark for modern emergency care delivery in Mumbai, and the unified 24/7 emergency helpline number 022 41114111 continues to enable rapid access to the hospital’s level 1 trauma centre.

 

About Fortis Healthcare Limited

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and day care specialty facilities. Currently, the company operates 36 healthcare facilities (including JVs and O&M facilities) across 12 states and union territories. The Company’s network comprises over 6,000 operational beds (including O&M beds) and 400 diagnostics labs.

nirā balance Transforming Lives Through Science and Nutrition: Co-Founders Ritesh & Dimple Bawri

Every February 14, the world celebrates the beauty of connection and the power of shared values. In the realm of health, this synergy is the very foundation of nirā balance a movement born from the belief that true wellness requires a perfect harmony between science and nutrition. While many see Valentine’s Day through the lens of romance, the story of nirā balance is one of purposeful collaboration.

 

Co-Founders nirā balance Ritesh Bawri & Dimple Bawri

 

The brand’s transformative approach was forged when nirā balance co-founder couple Ritesh and Dimple Bawri identified a critical gap in the wellness industry that shifted the focus from temporary fixes to long-term vitality. By combining scientific inquiry with expert nutritional strategy, nirā balance has evolved from a personal mission into a success story of holistic health.

 

Ritesh mentions an incident, a turning point in his life, which changed everything. He said during a dinner in the United States, a professor looked at me and said, “You are going to die!” The remark felt abrupt, but medical tests soon confirmed that his health was declining fast. Years of neglect had taken their toll, placing him at risk far earlier than he had imagined. 

 

He recalls, “At 38, I had achieved what society considers success: I was a fourth-generation business leader with multiple ventures and financial independence. Yet, despite my accomplishments, my health was deteriorating. I faced metabolic dysfunction, chronic fatigue, and early signs of cardiovascular disease. While the best doctors offered medications, my journey was about discovering the root causes of my challenges and reclaiming my vitality.”

 

Ritesh decided to radically rebuild his routine from the ground up, focusing on healthy meals, regular movement, and consistent sleep. The results were measurable. He shed excess weight, brought chronic conditions such as Type II diabetes, hypertension, hyperacidity, asthma, and insomnia under control, and recovered the stamina he thought he had lost. Determined to understand the science behind his recovery, Ritesh studied nutrition, cellular biology, and preventive health, and pursued certifications in physiology from Harvard Medical School and nutrition from Tufts University School of Medicine.

 

Dimple, his wife, played a crucial role in his journey, contributing significantly to what would later be called nirā balance. This approach now incorporates personalised nutrition frameworks that promote metabolic balance, sustained energy, and consistent health outcomes. With her keen aesthetic sense, eye for design, and natural empathy, Dimple ensured that the impact and appeal of nirā balance went beyond mere charts and lab reports.

 

She explains, “I have been an artist, and creativity comes naturally to me, so when we embarked on this journey being foodies boring food was never a choice. Nutrition is often viewed as all about strict diets and boring foods. I wanted to completely change that notion by showing how healthy eating can be fun and flavorful. I started experimenting at the ingredient level and curating recipes you look forward to eating, keeping nutrition, culture, and preferences in mind, making it effortless to follow. So simple that all you got to do is eat.” 

 

Together, they built nirā balance around a simple principle: care should feel personal, effortless, and evidence-based. Their earlier venture, BreatheAgain, established the foundation by providing structured guidance and close follow-ups to clients across different regions, paving the way for nirā balance.

 

Today, nirā balance integrates diagnostic precision with time-tested practices, tailoring plans to each individual’s needs. Ritesh leads science and systems with empathy, while Dimple shapes the experience and daily rituals that make change sustainable and effortless. In this way, their story embodies the spirit of Valentine’s Day. It goes beyond just flowers and gestures; it is about being there for one another and pursuing shared dreams every day. For Ritesh and Dimple, a second chance at health gave them a greater purpose, and today they inspire many others not just to get healthier but to live with purpose.

Maha Sivratri – World Yogi Day: Nandhiji's Programs Emphasize Stillness, Awareness, and Inner Transformation

Conscious greetings on the sacred occasion of Mahasivratri Grand Night — The Great Vigil of Leadership. The World Yogi Day movement is proud to announce a series of transformative programs led by Nandhiji, designed to deepen awareness and foster conscious leadership during this sacred window of time.

 

Maha Sivratri 2026 – Leadership Of Consciousness

 

Mahasivratri is the night of Turiya, the field of stillness beyond time, where awareness deepens, perception clarifies, and the mind gently yields to higher intelligence. It is a sacred opportunity to transcend inner limitations and rediscover the natural state of centered presence. Not merely a ritual observance, Mahasivratri is a vigil of heightened awareness where stillness intensifies, distractions lose their hold, and consciousness becomes more accessible. In this sacred space, leadership is refined at its true source — inner clarity.

 

Event Schedule and Participation Details:

  • MAHASIVRATRI GRAND NIGHT: The Great Vigil of Leadership

  • 15 February: 8:00 PM – 6:00 AM (Next Day) PST

  • 16 February: 9:30 AM – 7:30 PM IST

 

Register : MAHASIVRATRI: GRAND NIGHT OF LORD SIVA- FIVE EVENTS WITH NANDHIJI

Complementing this journey, the 108 Kshetras of Lord Siva, traditionally associated with pilgrimage, are contemplated as inner landscapes of awareness. Within subtle traditions of insight, they symbolise dimensions of transformation, discipline, transcendence, and awakened spiritual power.

 

Participants will have access to unique resources, including:

  • 108 One minute wisdom videos: Siddha Wisdom Blessings

  • Master Class with Nandhiji: Power of the Root Chakra, Pranayama, Mantra Deeksha, and Siddha Wisdom

  • Kalangi Kundalini Yoga DVD: For vitality, clarity, and spiritual power

  • Additional: Video recordings of Mahasivratri 2026

 

Across time zones and traditions, we gather in a shared vigil of awareness, honouring Siddha wisdom while deepening clarity, responsibility, and conscious leadership. May this sacred night awaken stillness, strength, and luminous perception within us all.

 

For more information and to register for these events, please visit www.worldyogiday.org.

Urban Land Institute's India Chapter to Convene Global and Indian Urban Leadership at its Largest-ever Annual Conference on the Future of Indian Cities

Urban Land Institute (ULI), a global non-profit and the oldest, largest network of cross-disciplinary land use experts, is set to host the fourth edition of its flagship ULI India Annual Conference in February. Scheduled for 26 February 2026 at the Four Seasons, Worli, Mumbai, the conference is anchored around the theme “Big Ideas Shaping Indian Cities.” It will bring together senior leaders from India and across Europe, the US, and Asia to examine the forces redefining the country’s urban future.

 

The ULI India team committed to advancing best practices in urban development and fostering meaningful industry dialogue

 

Established with the backing of ULI India’s founding partners Anarock, Blackstone, Brookfield, Hines, K Raheja Corp, RMZ Corp, and Xander, the ULI India Annual Conference has, in just four years, evolved into one of the country’s most influential independent platforms for urban dialogue. Supported in 2026 by a coalition of leading industry sponsors – led by Platinum Sponsor EAAA Alternatives; Gold Sponsors Arcadis, CapitaLand, Cushman & Wakefield, Gensler, and Phoenix Workspaces; and Silver Sponsors Aedas and Perkins Eastman – the conference comes at a pivotal moment, as Indian cities navigate global fragmentation, shifting capital flows, technological disruption, climate risk, and demographic change. The forum will move beyond projects and transactions to focus on how leadership, policy, and innovation can enable cities to adapt with purpose and resilience.

 

Attendees will include CEOs, CXOs, partners, investors, planners, policymakers, and senior leaders from real estate, infrastructure, finance, technology, architecture, and government bodies, reflecting the breadth of stakeholders shaping India’s urban future.

 

This year’s conference forms part of an expanded three-day experience, featuring curated study tours, UrbanPlan workshops, education roundtables, leadership engagements, and a full-day conference. A central highlight of the experience will be the ULI India Project Showcase, presenting 20 leading projects from across the country that reflect best practices in design, sustainability, and urban impact.

 

The programme will open with global and India-focused perspectives from Angela Cain, Global Chief Executive Officer, Urban Land Institute, and Dr. Parag Khanna, Founder and CEO, AlphaGeo, alongside a distinguished line-up of speakers including Amit Grover, Chief Executive Officer – City Side Development, Adani Airport Holdings Limited, Rohan Sikri, Managing Partner, The Xander Group Inc, Sandra Lee, CEO, Asia, BMS Group, and Jane Drummond, Chief Commercial Officer at Aon, APAC. Together, they will examine India’s position in a fragmenting global order and its implications for cities, capital, and long-term growth, setting the course for India’s urban future.


Throughout the day, over 20 senior industry leaders, policymakers, and global experts will address critical themes including domestic capital’s growing role in real estate, city-level transformation, the future of downtowns, emerging technologies, risk and insurance, and urban regeneration. Sessions will draw on both international experience and India’s evolving development models to offer actionable insights for decision-makers.

 

The conference will also feature a special collaboration with the Mumbai Metropolitan Region Development Authority (MMRDA), reinforcing ULI India’s commitment to strengthening dialogue between public institutions and private-sector leaders.

 

Speaking about the conference, ULI India’s Executive Director Manasvini Hariharan said, “Creating transformation in built environment is a long-term game. The impact isn’t visible tomorrow, but the conversations we have today will shape how our cities look 20 years from now. India has already entered a defining urban decade. The way we invest, govern, insure and design today will determine whether our cities offer real opportunity and quality of life for ourselves and the next generation. This conference is a convening catalyst, a space to challenge thinking, spark ideas, and turn dialogue into action that endures.”

 

Since its launch in 2023, ULI India has built a strong community of professionals committed to advancing responsible, inclusive, and resilient urban development. Through its research, convenings, and global network, ULI continues to position India within international conversations on city-making and sustainable growth.

 

With its most ambitious programme to date, the 2026 Annual Conference reinforces ULI India’s role as a neutral, high-trust platform shaping the future of Indian cities through collaboration, insight, and long-term thinking.

 

About Urban Land Institute
The Urban Land Institute (ULI) is a nearly 100-year-old, global, member-led, multidisciplinary organisation dedicated to shaping the future of the built environment for transformative impact in communities worldwide. Founded in 1936, ULI brings together professionals from across the real estate, finance, public, design, and academic sectors to advance responsible land use, foster better-planned and more liveable cities, and share practical knowledge through research, education, and convenings.

 

ULI India is the India chapter of the Urban Land Institute and is now in its fourth year. Since launching in 2023, it has built a growing community of around 200 members across the country, including developers, investors, policymakers, architects, planners, academics, and civil society leaders focused on the future of Indian cities. Through its councils, research, education initiatives, and flagship ULI India Annual Conference, ULI India provides a neutral, high-trust platform for dialogue, knowledge-sharing, and action on issues ranging from urban resilience and governance to capital flows, design innovation, and inclusive growth.

Mars Appoints Manish Syag as Managing Director for its Pet Nutrition Business in India

Today, Mars, Incorporated announced the appointment of Manish Syag as Managing Director of its Pet Nutrition division in India. Manish will lead the business, home to some of the country’s most trusted and pioneering pet food brands, including PEDIGREE®, WHISKAS®, SHEBA®, among others.
 

Manish Syag, Managing Director, Mars Pet Nutrition
 

Manish brings over two decades of FMCG leadership experience, having held senior sales leadership roles at Hindustan Unilever Limited (HUL) and GSK Consumer Healthcare. Manish joined Mars in 2024 as Chief Sales Officer and has played a key role in shaping the next phase of Mars India’s pet nutrition growth story. An alumnus of IIM Lucknow, Manish is widely regarded as a strong people leader with a proven ability to scale businesses while building high-performing teams. In his new role, Manish will drive a focused India Growth Agenda, build world-class operational capabilities, and strengthen the company’s leadership in the pet food industry one of the fastest emerging FMCG categories in the country.
 

Speaking on his appointment, Manish Syag said, “India is at a defining moment for the pet food market, which is expected to grow into a USD 2 billion category in a decade, evolving much as mainstream FMCG did in its early growth years, driven by access, awareness, and trust. I am excited to take on this role and lead the next phase of growth for our business in India, serving pets and pet parents across the country with trusted, high-quality packaged pet food by further strengthening our portfolio of deeply loved brands and expanding our market presence. At the heart of this journey will be our Mars Five Principles, and our Purpose: “A Better World For Pets.”
 

Manish succeeds Salil Murthy, who has been elevated to the role of Global Vice President, Enterprise Transformation, Mars Pet Nutrition. In this global leadership role, Salil will focus on advancing Mars Pet Nutrition’s long-term transformation agenda, strengthening leadership and organisational capability, and driving growth through building a simpler, faster and more future-ready operating model. Salil will be based in London, the site of Mars Pet Nutrition’s global headquarters.
 

Talking about his new role, Salil Murthy said, “I am excited to take on this new global role and help shape the future of Mars Pet Nutrition. This role offers an opportunity to focus on driving accelerated growth for the global Pet Nutrition business through unleashing the power of our associates across the world, strengthening our strategic resource allocation process and our digital and AI capabilities, and accelerating transformation to win with pet parents and our customers in every market. Leading the India Pet Nutrition business has been deeply fulfilling, and I’m incredibly proud of the growth we have driven and the high-performing team we have built over the last few years. I have every confidence in Manish’s leadership to take the business forward in its next phase of growth.”
 

Francisco Fernandez, Regional President, Mars Pet Nutrition – Rapid Growth Markets, said, “India is one of the most important growth markets for Mars Pet Nutrition. Salil’s elevation reflects the strong, purpose-led business he and the team have built in India and the depth of leadership talent emerging from this market. Manish’s appointment demonstrates our confidence in his expertise, leadership capability, and deep understanding of pet parents and customers in India. Together, these appointments reinforce our commitment to developing leaders from within and further strengthening India’s role in our global strategy and future growth of the business.”
 

Mars Pet Nutrition has been present in India since 2002, following the launch of PEDIGREE. In 2007, Mars established the country’s first pet food manufacturing facility, marking a key milestone in the development of the organized pet food category in India. Today, Mars Pet Nutrition serves millions of pets and pet parents across the country through its portfolio of trusted, high-quality products for both dogs and cats.

For more information about Mars, please visit www.mars.com. Join us on Facebook, Instagram, LinkedIn and YouTube.

Metropolis Healthcare's Centre of Genomics Hosts Multi-Specialty Genomics Symposium to Accelerate Precision Medicine in India

Ameera Shah-led Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), India’s second largest and the most trusted pathology laboratory chain, hosted a high-impact Scientific Symposium on Genomics, bringing together over 300 clinicians, researchers, scientists and academicians to advance the clinical integration of genomic diagnostics across India’s healthcare ecosystem. 

 

Eminent healthcare leaders and scientific experts at the Metropolis Centre of Genomics Scientific Symposium in Mumbai

 

The symposium also marked the formal unveiling of Metropolis’ Centre of Genomics to the clinician community, reinforcing the Company’s broader clinical engagement initiative focused on embedding advanced molecular diagnostics into routine medical practice. As precision medicine gains momentum in India and globally, the forum highlighted the shift from episodic testing to integrated, molecular-driven care pathways enabling earlier diagnosis, precise risk stratification, and personalised treatment across oncology, neurology, and women & child health.

 

Ms. Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare addressing at the Centre of Genomics Scientific Symposium

 

Across oncology, discussions centred on tumour profiling, biomarker-driven therapies, and the expanding role of next-generation sequencing in guiding targeted cancer care. Neurogenomics sessions examined inherited and rare neurological disorders, including genetic epilepsies and neuromuscular conditions, highlighting how genomic testing can reduce diagnostic delays and enable personalised management strategies. In women and child health, experts explored reproductive genomics, prenatal diagnostics, and genetic counselling, underscoring the role of early molecular insights in improving pregnancy outcomes and paediatric care. 


These thematic discussions were conducted through parallel sub-specialty sessions led by Key Opinion Leaders, Medical Advisory Board members, and distinguished national and international speakers, featuring panel discussions and case-based deliberations to deepen clinical engagement across specialties.


Clinicians also shared real-world case experiences demonstrating how genomics is enabling a transition from symptomatic management to evidence-based, targeted interventions, improving diagnostic clarity and reducing uncertainty in complex clinical scenarios. The discussions reflected a broader shift toward longitudinal, data-driven diagnostic journeys that support continuous and personalised patient management.


Commenting on the initiative, Ms. Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Limited, said, “The next phase of healthcare will be defined by how effectively genomic intelligence is embedded into clinical workflows at scale. The opportunity ahead lies in creating connected ecosystems where diagnostics, data science, and clinical expertise work seamlessly together. At Metropolis, we are focused on integrating molecular intelligence into everyday decision-making so that precision medicine moves toward becoming the standard of care, not the exception.”


Dr. Kirti Chadha, Chief Scientific and Innovation Officer, Metropolis Healthcare Ltd., said, “As genomic medicine expands, the real challenge is not access to technology but ensuring accuracy, interpretation, and accountability at every step. Scaling responsibly requires rigorous validation frameworks, structured reporting standards, and close collaboration between scientists and clinicians so that genomic findings are applied with clarity and confidence in patient care.”


The symposium featured participation from an eminent panel of national and international clinicians and experts, including Padma Shri and Padma Bhushan awardee Dr. Suresh Advani, Senior Consultant, Medical Oncology, Jaslok Hospital; Dr. Aniruddha Deshpande, Professor, Sanford Burnham Prebys, La Jolla, California; Prof. Stefan Bohlander, Department of Molecular Medicine, University of Auckland, New Zealand; Dr. Jyoti Bajpai, Senior Consultant, Precision Oncology, Sir H.N. Reliance Hospital and Apollo Hospital; Dr. Mehboob Basade, Senior Consultant, Medical Oncology, H.N. Reliance Hospital, Jaslok Hospital and Saifee Hospital; Dr. Anita Bhaduri, Senior Consultant, Histopathology, P.D. Hinduja Hospital, Mumbai; Dr. Charulata Sankhla, Neurologist, P.D. Hinduja Hospital, Mumbai; Dr. Rahul T. Chakor, Neurologist, Nair Hospital, Mumbai; Dr. Neelu Desai, Paediatric Neurologist, P.D. Hinduja Hospital, Mumbai; Dr. Pradnya Gadgil, Senior Consultant, Paediatric Neurology and Complex Epilepsy, SRCC Children’s Hospital; Dr. Mayank Nilay, Clinical Geneticist, Post Graduate Institute of Child Health, Noida; Dr. Sunita Tandulwadkar, Ex-President, FOGSI and Chief IVF Consultant and Endoscopist, Ruby Hall Clinic, Pune; Dr. Chander Lulla, Consultant Sonologist and Fetal Medicine Specialist, Head – Ultrasound, Jaslok Hospital, Mumbai and Senior Consultant at Reliance HN Hospital and Ria Clinic; and Dr. Anupkumar Rawool, Senior Consultant Clinical and Cancer Geneticist, Founder and Director, Sahaj Genetic Clinic, Pune.

 

About Metropolis Centre of Genomics 
The Centre of Genomics at Metropolis Healthcare Limited is an integrated precision diagnostics platform built on the Company’s long-standing expertise in molecular diagnostics and precision oncology. Bringing together two CAP-accredited national referral laboratories, advanced next-generation sequencing technologies, and multidisciplinary scientific expertise, the Centre delivers clinically actionable genomic medicine across India.

 

It supports high-impact specialties including oncology, neurology, reproductive health, transplant immunology, and rare diseases through a comprehensive portfolio of NGS-based assays, robust bioinformatics, clinical interpretation, and genetic counselling across the care continuum. By combining cutting-edge technology with strong clinical governance and scientific stewardship, the Centre transforms complex genomic data into actionable intelligence, enabling earlier diagnosis, targeted therapies, and personalised patient management.

 

Beyond its current capabilities, the Centre of Genomics serves as a platform for continuous test development, AI-enabled analytics, and deeper digital integration to further strengthen clinical outcomes and operational excellence. With active engagement in pharmaceutical programs, clinical trials, and international collaborations, it is positioned as a strategic partner for global research, companion diagnostics, and precision-led drug development.

 

About Metropolis Healthcare Limited 
Established in 1981, Metropolis Healthcare Limited is India’s second-largest diagnostic chain, led by visionary leader Ms. Ameera Shah, Promoter and Executive Chairperson. With over four decades of excellence, Metropolis has been a pioneer in delivering best-in-class diagnostic services to patients, healthcare providers, and corporates across India and Africa. The company’s extensive footprint spans 28 states, 7 Union Territories, and over 750 towns in India, supported by a robust network of more than 220 laboratories, 4,800+ service centers, and over 10,000 touchpoints. 

 

Each year, Metropolis serves millions of individuals by providing actionable health insights that empower better clinical outcomes. Metropolis offers a comprehensive range of more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. The company’s commitment to quality and accuracy is reinforced by its consistent CAP proficiency score of over 98% for the past decade, placing it among the top 1% of laboratories worldwide for quality assurance. The Metropolis philosophy is built on the pillars of technological superiority, a warm, patient-centric approach, and reliable diagnostic reports. 

 

For more information, please visit www.metropolisindia.com or click on Twitter, Facebook, or LinkedIn.

Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth

Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26.

 

Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The international branded formulation segment more than doubled sequentially led by demand recovery across its key markets.

 

Adj EBITDA increased 21% YoY to Rs 147 cr as better capacity utilization along with a steady ramp up in the newer facilities led to margin improvement. Tighter control over overheads and portfolio rationalization helped mitigate losses in the API and Trade generics segment as well.

 

Our march towards becoming a global manufacturing company continued unabated with the Company receiving European Union Good Manufacturing Practice (EU GMP) certification for two of its manufacturing facilities. The certification includes the renewal of EU GMP approval for our Oral Solids’ plant and the grant of EU GMP certification for our Oral Liquids Plant. Akums also received its first approval from the UK MHRA for Rivaroxaban tablets

 

Commenting on the development, Mr. Sandeep Jain, Managing Director, stated, “The EU GMP certifications reflect the strength of our compliant infrastructure, robust quality systems, and the expertise of our skilled teams. We remain focused on disciplined growth while steadily strengthening our presence in regulated markets.

 

Mr. Sanjeev Jain, Managing Director, added, “Our continued focus on operational excellence and disciplined growth is aligned with our long-term global vision, enabling us to expand responsibly across regulated markets and strengthen partnerships worldwide.”

 

Highlights are as under: (Rs in Crores)

Particulars

Q3FY 26

Q3FY 25

YoY change

Q2FY 26

9MFY26

9MFY25

YoY change

Revenue

1,160

1,010

14.8%

1,018

3,201

3,063

4.5%

Adj EBITDA

147

121

21.0%

94

370

367

1.0%

Adj EBITDA

Margin

12.7%

12.0%

 

9.3%

11.6%

12.0%

 

Adj PAT

86

66

29.5%

43

193

190

1.6%

Adj PAT Margin

7.2%

6.5%

 

4.1%

5.9%

6.1%

 

 

Knowledge Without Borders: Galgotias University Strengthens India–Arab Higher Education Collaboration

In its continuous tryst to strengthen global education excellence and academic leadership, Galgotias University reaffirmed its commitment at the India–Arab University Presidents’ Summit held at Ajman University today.

 

Dr. Dhruv Galgotia at the India–Arab University Presidents’ Summit

 

The summit’s Presidential Roundtable, titled From Vision to Action, convened higher education leaders to explore strategic pathways for cross-border collaboration, research excellence, and innovation ecosystems.

 

Dr. Dhruv Galgotia, CEO, Galgotias University, represented the institution in focused discussions that highlighted the importance of implementation-led leadership in strengthening ties between Indian and Arab academic communities.

 

This roundtable facilitated constructive dialogue among university presidents, resulting in commitments toward action-oriented partnerships that promise to enhance global academic alignment and collaborative opportunities.

 

While addressing the delegates, Dr. Dhruv Galgotia, CEO, Galgotias University, said, “Galgotias University strongly believes that fostering meaningful international partnerships is essential for advancing research, nurturing innovation, and preparing students for global challenges”

 

“The India–Arab collaboration underscores our shared vision of education without borders. We are committed to contributing to a future where knowledge flows freely and institutions work together to create impact that transcends geography,”  he added.

 

Dr. Galgotia also expressed his appreciation to Dr. Ashwin Fernandes for bringing together leaders and presidents from diverse institutions and extended special thanks to Ajman University for the exceptional planning and execution of the summit.

 

The summit marks a significant milestone in Galgotias University’s efforts to strengthen international academic networks and promote global leadership in higher education.

 

About Galgotias University   

Galgotias University Among the World’s Leading Universities in QS and THE Rankings 

 

Galgotias University proudly ascends in the QS World University Rankings 2026 by Quacquarelli Symonds, securing a coveted position in the 1201–1400 global band. Ranked 15th among top private universities and 43rd among all Indian universities—public and private combined—this achievement marks a powerful endorsement of Galgotias’ unwavering commitment to academic excellence, global relevance, and innovation in higher education. 

 

In the Times Higher Education (THE) World University Rankings 2025, Galgotias University has been ranked 45th among Indian universities (including both government and private institutions) and placed in the globally prestigious 1001–1200 band. This significant achievement reinforces the university’s growing stature in the international academic arena and validates its consistent progress in global higher education benchmarks. 

 

These recognitions reflect Galgotias University’s strategic focus on teaching quality, research impact, internationalization, and industry relevance, and its mission to shape globally competent graduates prepared for the challenges of tomorrow. 

 

Bisleri International Partners with Edathala Gram Panchayat and Green Worms for Community-Led Waste Management Awareness Drive under 'Bottles for Change'

Bisleri International, India’s leading packaged drinking water company has partnered with Edathala Grama Panchayat, and Green Worms Waste Management Private Limited for a door-to-door waste management and public awareness campaign. As part of Bisleri’s Bottles for Change initiative, the campaign is being rolled out across wards of the panchayat with the objective of strengthening waste management practices and reinforcing mandatory segregation at source at the household level. 

 

Bisleri, Edathala Gram Panchayat & Green Worms launch a community-led waste awareness drive under ‘Bottles for Change’


The initiative is also aligned with the Government of Kerala’s Malinya Muktha Keralam (Waste-Free Kerala) mission which supports efforts to reduce pressure on public dumping sites and promote sustainable local waste management systems.


The campaign brings together the efforts of the local self-government, implementation partner Green Worms, and grassroots institutions including the Haritha Karma Sena and Kudumbashree units, who will lead field-level outreach and community engagement. Alongside the structured collection of plastic waste, the initiative places strong emphasis on sustained public interaction to encourage long-term behavioural change towards responsible waste disposal.


Speaking on the initiative, Mr. K. Ganesh, Director – Sustainability & Corporate Affairs, Bisleri International Pvt. Ltd., said, “Building sustainable waste management systems requires long-term engagement, strong partnerships and active community participation. Through Bottles for Change, Bisleri continue to work closely with local bodies and organisations to strengthen segregation at source and enable households to participate meaningfully in the circular economy. This collaboration with the Edathala Panchayat, partnering with them lays the foundation for sustained environmental impact driven by collective action.”


Highlighting the long-term vision of the initiative, Mr Mohammed Jamsheer, Managing Director, Green Worms Waste Management stated, “Waste management is not merely a project; it is a culture. A clean Kerala can become a reality only when waste segregation becomes a habit in every household. By integrating CSR initiatives like Bisleri International’s ‘Bottles for Change’ with the dedicated efforts of the Haritha Karma Sena, Kudumashree we can create sustainable and lasting social change. The progress seen in Edathala reflects the strength of this collaborative approach.”


The campaign began with an orientation session for elected representatives and Haritha Karma Sena members. The session focused on the principles of the plastic circular economy, global best practices in waste segregation, and the role of community participation in strengthening decentralised waste management systems. 


The week-long drive will sensitise households about source segregation of plastic reducing consumption, reusing, and recycling. The aim is to achieve measurable environmental outcomes, including large-scale collection of non-biodegradable waste and ensuring its diversion to recycling rather than landfills and oceans.


Through Bottles for Change, Bisleri International partners with urban local bodies, state governments, and implementation agencies across India to advance responsible plastic waste management. The initiative combines public awareness, capacity building, and on-ground infrastructure to create scalable, community-led solutions.


About Bisleri International Pvt. Ltd.
With a legacy of over 50 years, Bisleri International Pvt. Ltd has grown to become one of the largest premium beverage businesses in India. Being the makers of the country’s largest-selling packaged drinking water, Bisleri follows a stringent process of 114 quality tests and a 10-stage purification. It remains true to its core value of providing consumers with pure, safe and healthy water.


Bisleri International has a strong presence with 128 operational plants and a robust distribution network of over 6,000 Distributors and 7,500 Distribution Trucks across India and UAE market. It offers a range of beverages that are produced for all occasions. Whether it is the promise of goodness, trust, and purity with Bisleri packaged drinking water, or a daily dose of health offered through Vedica Himalayan Spring Water. Besides, Bisleri International has ventured into fun-filled refreshments with a diverse range of carbonated drinks available in multiple flavours, such as Bisleri Limonata, Bisleri Rev, Bisleri Spyci Jeera, Bisleri Pop and Bisleri Soda. These Bisleri products are also available on the e-commerce platform – Bisleri@Doorstep. This D2C platform reassures customers that they will receive a safe and uninterrupted supply of their most trusted brand at their doorstep.


The core values of Bisleri International lie in yielding growth and embedding sustainability by being responsible in all aspects of the business. The organization has unveiled Sustainability 2.0 with Bisleri Greener Promise that focuses on creating greener future for all through implementing initiatives under the program of recycling, water conservation and sustainability. For more information on Bisleri International, our people, brands, and OSR initiatives, visit www.bisleri.com.